Annual Meeting

Key:
[C] Clinician – Indicates sessions of interest to practicing clinicians
[YI] Young Investigator – Indicates Sessions of interest to young investigators, those attendees early in their research careers
[W&M] Women and Minorities – Indicates sessions of interest to women and other minorities

Friday, September 12, 2008

[C] ASBMR/ECTS Co-Sponsored Clinical Debate: Monitoring the Effects of Treatment of Osteoporosis – Is It Worthwhile?

1:00 p.m. – 2:00 p.m.

Co-Chairs:
Rajesh Thakker, M.D., University of Oxford (UK)
Bess Dawson-Hughes, M.D., Tufts University

Debaters:
John Bilezikian, M.D., Columbia University
Juliet Compston, M.D., FRCP, University of Cambridge School of Clinical Medicine (UK)

Saturday, September 13, 2008

[YI and W&M] New Investigator/New Member Breakfast

7:00 a.m. - 8:00 a.m.

Sponsored by the ASBMR Membership Development Committee

New Investigators (those early in their careers) and new ASBMR members are invited to join the ASBMR Membership Development Committee and colleagues for an informational breakfast. The format for this annual event has been changed this year to allow more time for participants to interact with one another. Program directors from U.S. NIH Institutes and Centers, the Canadian Institues of Health Research and the Institute of Musculoskeletal Health and Arthritis, ASBMR member senior scientists and representatives from several ASBMR committees will be available for discussion at specially marked tables. Breakfast will be provided.

[YI and C] Special Session for Allied Health Professionals

12:00 p.m. – 2:00 p.m.

Featuring an Overview of the 30th Annual Meeting by Lawrence Raisz, M.D.

This special session is of interest to allied health professionals, first time meeting attendees, individuals new to the field, nurses, clinical research study coordinators, physical therapists and/or those seeking guidance in navigating through the extensive ASBMR program.

Co-Chairs:
Diane C. Krueger, B.S., C.C.R.C., University of Wisconsin
Joan M. Lappe, R.N., Ph.D., F.A.A.N., Creighton University Medical Center
Betsy C. McClung, R.N., M.N., Oregon Osteoporosis Center

Overview of the ASBMR 30th Annual Meeting
Lawrence Raisz, M.D., University of Connecticut Health Center

How Osteocytes Communicate with Each Other and with Cells on the Bone Surface
Lynda F. Bonewald, Ph.D., Kansas City Dental School

Bone Metastases: Current and Future Treatment Strategies
G. David Roodman, M.D., University of Pittsburgh Medical Center

[C] Clinical Roundtable/Case Conference: Osteoporosis

12:30 p.m. – 1:30 p.m.

Chair:
B. Lawrence Riggs, M.D., Mayo College School of Medicine

Premenopausal Osteoporosis
Ian Reid, M.D., MBChB, University of Aukland (New Zealand)

Postmenopausal Osteoporosis
Robert Recker, M.D., Creighton University

[C]New Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism

1:30 p.m. – 2:30 p.m.

Over the past 6 years, since the last Workshop on the diagnosis and management of asymptomatic primary hyperparathyroidism, new knowledge has been gained including its molecular pathogenesis, natural history, atypical manifestations, preoperative localization and medical and surgical management. This symposium will summarize the results of the Third International Workshop on the Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism, held in Orlando, FLA, on May 13, 2008. The symposium will also present management guidelines, revised since the last conference was held, in 2002. Co-chaired by Maria Luisa Brandi and Shonni Silverberg, speakers for this session include John Bilezikian, Richard Eastell, Aliya Khan and John Potts.

Sunday, September 14, 2008

[C] Improving Patient Care: Implementing Clinical Practice Quality Measures for Osteoporosis

11:30 a.m. – 12:30 p.m.

Co-sponsored by ASBMR Professional Practice Committee, the National Osteoporosis Foundation, the International Society for Clinical Densitometry and the American Academy of Orthopaedic Surgeons

Despite advances in osteoporosis detection and treatment, osteoporosis continues to be poorly managed, under-treated and under-diagnosed. To address this problem, system solutions which rely on quality measures are needed. The first step was the HEDIS measure for evaluating performance by managed care providers. Subsequently both the American Medical Association (AMA) and the Joint Commission (formerly the Joint Commission on Accreditation of Healthcare Organizations (JCAHO)) have developed quality measures for the prevention, identification and management of osteoporosis, but neither set of measures has been tested and implementation of each remains uncertain. The goal of this session is to consider both sets of quality measures and explore the options for implementation currently under consideration. Presentations will highlight what steps must be taken before osteoporosis quality measures can be realized, including:

• Prioritizing the quality measures for implementation, based on science and feasibility
• Identifying common language between the AMA and Joint Commission sets of measures
• Pilot testing the measures to discern if they can be implemented

Welcome and Introductions
Robert A. Adler, M.D., McGuire VA Medical Center , ASBMR Professional Practice Committee Chair

How the Joint Commission Measures will Affect Institutions
Ethel S. Siris, M.D., Columbia University College of Physicians & Surgeons

American Medical Association Measures: Implications for Clinicians
Kenneth G. Saag, M.D., M.Sc., University of Alabama at Birmingham

Osteoporosis Quality Measures: An Orthopaedic Surgeon’s Perspective
Joseph Zuckerman, M.D., NYU Hospital for Joint Diseases

The Reality of Performance Measures
Stuart L. Silverman, M.D., The OMC Clinical Research Center

Questions and Answers/Panel Discussion
Moderator: Robert A. Adler, M.D., McGuire VA Medical Center, PPC Chair

[C] Clinical Roundtable/Case Conference: Paget's Disease and Fibrous Dysplasia: Issues and Controversies Regarding Treatment

12:30 p.m. – 1:30 p.m.

Chair:
Michael Whyte, M.D., Washington University School of Medicine in St. Louis

Paget's Disease: When to Treat (and Re-treat)
Ethel Siris, M.D., Columbia University Medical Center

Fibrous Dysplasia of Bone
Frederick Singer, M.D., John Wayne Cancer Institute

[YI] [W&M] Women in Bone and Mineral Research Meet-the-Professor Session: Growing Your Career and Balancing Life

11:30 a.m. – 12:30 p.m.

The ASBMR Women in Bone and Mineral Research Committee invites you to its inaugural Meet-the-Professor session. This session will focus on the challenges of developing a progressive career path while maintaining a balanced life. Speakers include Phoebe Leboy, Ph.D., Juliet Compston, M.D., FRCP, and Rachelle Galvin, Ph.D.

Monday, September 15, 2008

Forum - National Action Plan for Bone Health

11:30 p.m. - 12:30 p.m.

The release of Bone Health and Osteoporosis: A Surgeon General’s Report in October 2004 brought national attention to osteoporosis and related bone diseases. As a result, public and private sector organizations have taken action to disseminate the messages of the report through the media and organizational activities and programs. The National Coalition for Osteoporosis and Related Bone Diseases, a coalition comprised of the American Society for Bone and Mineral Research, the National Osteoporosis Foundation, the Osteogenesis Imperfecta Foundation and The Paget Foundation, has convened a National Summit to develop a coordinated national action plan to promote bone health. A report will be presented on the recommendations resulting from the Summit for a National Action Plan for Bone Health held in June 2008 in Washington, DC, with objectives including:

• Developing a national action plan to increase awareness by the public and health care professionals on the prevention, diagnosis and treatment of osteoporosis and related bone diseases
• Establishing priority recommendations for policies and programs for health care professionals, health systems and population-based approaches to promote bone health
• Engaging key stakeholder groups in taking action on priority recommendations established at the Summit
• Initiating a long-term implementation and evaluation effort that will be coordinated by a planning group of public and private organizations

[YI] Young Investigator Meet-the-Professor Session: Obtaining Your First Faculty Position

11:30 a.m. – 12:30 p.m.

Sponsored by the ASBMR Membership Development Committee and Young Investigator Subcommittee

The goal of this Meet-the-Professor session is to provide attendees early in their careers the chance to hear from a diverse panel of both senior and junior academic faculty appointees who can share their experiences and provide insight into the process. Discussion will include useful “how to” advice; touch on the benefits of mentorship; pointers about positioning yourself to successfully obtain your first faculty position and guidance for avoiding common pitfalls that can derail a young investigator. Panelists include Melissa Kacena, Ph.D., Nicola Partridge, Ph.D., Rajesh Thakker, M.D., FRCP and Michael Econs, M.D.

[C] Clinical Roundtable/Case Conference: Hypercalcemia

12:30 p.m. – 1:30 p.m.

Chair:
Shonni Silverberg, M.D., Columbia University Medical Center

Recalcitrant Hypercalcemia
Paul Miller, M.D., Colorado Center for Bone Research

Hypercalcaemia in Chronic Renal Disease
Keith Hruska, M.D., Washington University School of Medicine in St. Louis

[YI] Writing a Winning Grant

12:30 p.m. – 2:00 p.m.

Co-sponsored by ASBMR Membership Development and Education Committees

U.S. and international investigators at all career levels are urged to attend this interactive forum which will include grant writing fundamentals, grant resubmission strategies and an “insider’s perspective” on winning NIH grants. This session is a can’t miss opportunity for anyone writing a research grant or wanting to gain invaluable insight into the grant writing process.

Welcome and Introduction
Suzanne Jan de Beur, M.D., Johns Hopkins University, Membership Development Committee Chair
Merry Jo Oursler, Ph.D., Mayo Clinic, Education Committee Chair

Fundamentals of Writing a Winning Grant
Larry G. Raisz, M.D., University of Connecticut Health Center

Ins and Outs of Resubmitting a Grant
Robert A. Nissenson, Ph.D., University of California, San Francisco

Submitting Your Grant to the U.S. National Institutes of Health (NIH)
Joan A. McGowan, Ph.D., National Institute of Arthritis, Musculoskeletal & Skin Disease

Submitting Your Grant to the Canadian Institues of Health Research (CIHR)
Jane Aubin, Ph.D., Institue of Musculoskeletal Health and Arthritis (Canada)

Q & A – Panelist Discussion: Speakers
Following the formal presentations, speakers and session co-chairs will participate in a panel discussion and answer questions from the audience.

[YI and W&M] The Women in Bone and Mineral Research Committee Event

6:00 p.m. - 8:00 p.m.

Sponsored by the ASBMR Women in Bone and Mineral Research Committee

Registration Fee: $35 ($15 students/trainees)

This annual Women's Event is open to all attendees interested in learning about the future of women in academic medicine. The ASBMR Women in Bone and Mineral Research Committee (WBMRC) was established in 2005. This committee is charged with mentoring women in the Society with respect to career advancement, academic promotions, combining a career with family, etc. The WBMRC invites you to join them to hear Harold L. Paz, M.D., Senior Vice President for Health Affairs, Dean, Penn State College of Medicine, and Chief Executive Officer, Penn State Milton S. Hershey Medical Center, to discuss Gender Equity and the Future of Academic Medicine. Dinner and wine will be served with ample time for networking with peers.